Sort
30,917 grants matching “tumor microenvironment”
Project 1 Extracellular Vesicles (EVs) Role in GBM Pathobiology
$284,671Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2018 · CA
The Role of Ubiquitin-Proteasome Pathway in Myeloma Bone Disease
$284,634Babatunde Olukayode Oyajobi · Vanderbilt University · P01 · FY2010 · CA
Etanercept Therapy in Follicular Lymphoma
$284,611Dana-Farber Cancer Institute · R21 · FY2003 · CA
ADHESION AND ERK SIGNALING IN MELANOMA
$284,589Andrew E Aplin · Thomas Jefferson University · R01 · FY2013 · GM
Project 2: Translating Genomics to Practice to Overcome Disparities in Diffuse Large B-Cell Lymphoma (DLBCL)
$284,568Christopher R Flowers · University Of Tx Md Anderson Can Ctr · U54 · FY2025 · CA
Project 3: AI Digital Pathology Tools to Address Disparities in Lymphoma Diagnosis and Classification for Underserved Communities
$284,568Lee Cooper · University Of Tx Md Anderson Can Ctr · U54 · FY2025 · CA
Project 1: Precision targeting of therapeutic vulnerabilities specific to African American lymphoma patients
$284,568Christopher R Flowers · University Of Tx Md Anderson Can Ctr · U54 · FY2025 · CA
Radiation Res & Translational Biology
$284,555Karen E Knudsen · Thomas Jefferson University · P30 · FY2016 · CA
Radiation Res & Translational Biology
$284,555Karen E Knudsen · Thomas Jefferson University · P30 · FY2017 · CA
Radiation Res & Translational Biology
$284,555Karen E Knudsen · Thomas Jefferson University · P30 · FY2015 · CA
CpG Plus Rituximab Therapy in Follicular Lymphoma
$284,550Dana-Farber Cancer Institute · R21 · FY2004 · CA
Role of genomic and microenvironment factors in conferring acquired resistance to ferroptosis to chemoradiation in esophageal adenocarcinoma
$284,543Steven Hsesheng Lin · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
Retinoid Nutritional Status and Immune Function
$284,542A Catharine Ross · Pennsylvania State University, The · R01 · FY2009 · DK
PDX tumor-TME acquired resistance
$284,529Jack Roth · University Of California, San Francisco · U54 · FY2025 · CA
T cell therapy targeting multiple tumor antigens in lymphoma
$284,505Ann M. Leen · Baylor College Of Medicine · P50 · FY2018 · CA
Project 1 Extracellular Vesicles (EVs) Role in GBM Pathobiology
$284,382Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2021 · CA
Project 1 Extracellular Vesicles (EVs) Role in GBM Pathobiology
$284,348Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2020 · CA
Arginase Production in Cancer: Evading Immune Response
$284,260Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2006 · CA
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
$284,228Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2013 · CA
NF-kB mediated induction of VEGFR-3 and new lymphatic vessels in breast cancer
$284,206Sophia Ran · Southern Illinois University Sch Of Med · R01 · FY2014 · CA
SUBNUCLEAR TARGETING AND TRANSCRPTIONAL CONTROL DURING INTERPHASE AND MITOSIS IN
$284,159Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2008 · CA
Molecular Dissection of the Angiogenic Response induced by VEGF-A
$284,129Harold Fisher Dvorak · Beth Israel Deaconess Medical Center · P01 · FY2013 · CA
Development of Salmonella vaccines for cancer and viruses
$284,119Olivia Steele-Mortimer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Mechanisms of Cell-Cell Interaction in Tumor Growth and Metastasis in Flies
$284,065Tian Xu · Yale University · R01 · FY2013 · CA
Project 3: HHLA2 as a THerapeutic Target in RCC
$284,060David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2021 · CA